Vote Scores
Filings read through

How funds voted at iTeos Therapeutics, Inc.

Filers reporting
83, year to 30 June 2025
Latest meeting on file
Meetings on file
2

In the year to 30 June 2025, 83 filers on Form N-PX reported votes at iTeos Therapeutics, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 160 marks to the ballot items, each with or against management. 78.8% of the marks are with management.

In the year to 30 June 2025, no say-on-pay item is on file for iTeos Therapeutics, Inc.. So there is no figure to give.

By filers reporting in the year to 30 June 2025, iTeos Therapeutics, Inc. was number 3,953 of 11,807 companies with a page and votes in that year. The number of filers reporting at iTeos Therapeutics, Inc. fell by 5.7% from the year to 30 June 2024 to the year to 30 June 2025. At the companies on this site with filers in both years, the total of filers reporting rose by 4.1%. In all seasons on file, category AUDIT-RELATED is 28.7% of the vote records at iTeos Therapeutics, Inc.. At all companies on this site, it is 6.8%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 17 Jun 2025

83 filers reported votes at this meeting in the year to 30 June 2025. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 60.1% of the reported votes are for. 57 filers withheld from or voted against at least one nominee.

    459 vote records from 83 filers. 33 of the 80 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 32 fund families
    • For 19
    • Abstain or withhold 13
    • Against management 13
  2. Item 2: Audit-related items (auditor ratification)

    153 vote records from 83 filers. 1 of the 80 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 32 fund families
    • For 32

Positions of the fund families at the meeting of 17 Jun 2025

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Every meeting on file

Meetings of iTeos Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2025832not reported
year to 30 June 2024882not reported

Say-on-pay, season by season

Say-on-pay at iTeos Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202583not reportednot reported
year to 30 June 202488not reportednot reported
iTeos Therapeutics, Inc. and the median of companies on this site, year to 30 June 2025
Say-on-payThis companyMedian of companies on this site
Filers against managementnot reported8.1%
Reported shares against managementnot reported4.0%

The median covers 3,794 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at iTeos Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS78571.3%
AUDIT-RELATED31628.7%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at iTeos Therapeutics, Inc.. https://votescores.com/company/iteos-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of iTeos Therapeutics, Inc. are on file?
2 meetings are on file, from 11 Jun 2024 to 17 Jun 2025. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at iTeos Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2025. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. iTeos Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list iTeos Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .